Calcium-channel blockers: Nursing Pharmacology
Notes
CALCIUM-CHANNEL BLOCKERS | ||
DRUG NAME | Dihydropyridines: nifedipine (Procardia, Adalat), amlodipine (Norvasc), clevidipine (Cleviprex), nicardipine (Cardene), felodipine (Plendil), nimodipine (Nimotop) Non-dihydropyridines: diltiazem (Cardizem), verapamil (Calan, Isoptin) | |
CLASS | Calcium Channel Blockers (CCB) | |
MECHANISM OF ACTION |
| |
INDICATIONS |
| |
ROUTE(S) OF ADMINISTRATION |
| |
SIDE EFFECTS |
| |
CONTRAINDICATIONS AND CAUTIONS |
|
NURSING CONSIDERATIONS: CALCIUM-CHANNEL BLOCKERS | ||
ASSESSMENT AND MONITORING |
| |
CLIENT EDUCATION |
|
Sources
- "Focus on Nursing Pharmacology" LWW (2019)
- "Pharmacology - A Patient-Centered Nursing Process Approach (8e)" Elsevier Health Sciences (2014)
- "Saunders Comprehensive Review for the NCLEX-RN Examination" Saunders (2020)
- "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2018)
- "First Aid for the USMLE Step 1 2018, 28th Edition" McGraw-Hill Education / Medical (2018)
- "Rang and Dale's Pharmacology" Elsevier (2018)
- "Basic & Clinical Pharmacology (15e)" McGraw Hill (2021)
- "Calcium Channel Blockers" StatPearls [Internet] (2021)
- "Calcium Channel Blocker" Wikipedia ()
- "Mosby's 2021 Nursing Drug Reference" Mosby (2021)